Laparoscopic Versus Ultrasound Guided Block in Sleeve Gastrectomy
Conditions: Postoperative Pain Interventions: Procedure: postoperative pain Sponsors: Biruni University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy(LSG)
Conditions: Acute Kidney Injury; Bariatric Surgery Candidate; Gabapentin Interventions: Drug: Gabapentin; Drug: Placebo Sponsors: Tanta University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Online Exercise Program During Perioperative Treatment in Adults With Gastric Cancer
Conditions: Gastric Cancer Interventions: Behavioral: Exercise Training Sponsors: University of Maia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Gut Microbiome Intervention (EXL01) With Nivolumab and FOLFOX in First-line Treatment for PD-L1 CPS ≥5 Metastatic Gastric Cancer: GERCOR Phase II Study (BIG)
Conditions: Gastric Cancer Interventions: Drug: Nivolumab; Drug: FOLFOX regimen; Biological: EXL01 Sponsors: GERCOR - Multidisciplinary Oncology Cooperative Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease
Conditions: Gastric Cancer; HER2-positive Gastric Cancer Interventions: Drug: Experimental; Drug: Control Sponsors: Gruppo Oncologico del Nord-Ovest Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly
Conditions: Gastro-enteropancreatic Neuroendocrine Tumor; Acromegaly Sponsors: Ipsen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
A Study on the Prognosis of Two Different Surgery Methods in Patients With Rectal Endometriosis
Conditions: Gastrointestinal Function; Quality of Life; Pregnancy Outcomes Interventions: Procedure: disc resection; Procedure: segmental resection Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
Conditions: Metastatic Solid Cancers; Colorectal Cancer; Breast Cancer; Non-Small Cell Lung Cancer; Gastrointestinal Cancer; Ovarian Cancer; Genitourinary Cancer Interventions: Drug: Aldesleukin; Drug: Fludarabine; Drug: Cyclophosphamide; Biological: KRAS TCR-Transduced PBL; Biological: GRT-C903/GRT-R904 Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Oral PEG vs. Enema in Urgent Colonoscopy for ALGIB
Conditions: Acute Lower Gastrointestinal Bleeding Interventions: Other: Enema Bowel preparation; Other: PEG Bowel preparation Sponsors: Beijing Friendship Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
Conditions: Gastric Cancer Interventions: Drug: Nivolumab; Drug: FOLFOX regimen; Biological: EXL01 Sponsors: GERCOR - Multidisciplinary Oncology Cooperative Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
Conditions: Metastatic Esophageal Carcinoma; Advanced Unresectable Gastric Adenocarcinoma; Metastatic Gastric Cancer; Metastatic Gastroesophageal Junction Adenocarcinoma; Metastatic Esophageal Cancer; Metastatic Esophageal Adenocarcinoma; Metastatic Gastric Adenocarcinoma; Metastatic Gastric Carcinoma; Unresectable Esophageal Cancer; Unresectable Esophageal Adenocarcinoma; Unresectable Gastric Carcinoma; Unresectable Gastric Adenocarcinoma; Unresectable Gastroesophageal Junction Adenocarcinoma Interventions: Biological: AgenT-797; Biological: Botensilimab; Drug: Balstilimab; Drug: Ramucirumab; Drug: Paclitaxel Sponsors: Me...
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction
Conditions: PD-1; Neoadjuvant Chemoradiotherapy; Gastroesophageal Junction Cancer Interventions: Drug: PD-1inhibitor Sponsors: Wuhan Union Hospital, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Peri-operative Zimberelimab (Anti-PD-1) vs Zimberelimab in Combination With Domvanalimab (Anti-TIGIT) in Resectable Mismatch Repair Deficient/Micro-satellite Unstable Gastric and Gastro-oesophageal Junctional Adenocarcinoma (ZODIAC)
Conditions: Metastatic Esophageal Cancer; Metastatic Gastric Cancer Interventions: Drug: Single agent zimberelimab; Drug: Combination zimberelimab + domvanalimab Sponsors: Royal Marsden NHS Foundation Trust; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer
Conditions: Advanced Gastric Adenocarcinoma and Esophageal Squamous Cell Carcinoma Interventions: Drug: SHR-8068;Adebrelimab;Oxaliplatin;Capecitabine Tablets;Paclitaxel Injection;Cisplatin Injection; Drug: Adebrelimab;Oxaliplatin;Capecitabine Tablets;Paclitaxel Injection;Cisplatin Injection Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer
Conditions: Gastric Adenocarcinoma; Gastric Cancer; Microbiome; Cytokines; Nutritional Status Interventions: Dietary Supplement: Formulation with probiotics; Other: Non-intervention for Clinical Outcomes -G5 Sponsors: Universidade Federal do Amazonas Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
